Literature DB >> 9734694

Erythropoietin, with and without granulocyte-colony stimulating factor (G-CSF), in the treatment of myelodysplastic syndrome (MDS) patients.

K Miller1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9734694     DOI： 10.1016/s0145-2126(98)00035-6

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  2 in total

Review 1.  The myelodysplastic syndromes: morphology, risk assessment, and clinical management (2002).

Authors:  John M Bennett; Peter A Kouides; Stephen J Forman
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 2.  Myelodysplastic syndromes.

Authors:  K B Miller
Journal:  Curr Treat Options Oncol       Date:  2000-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.